×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
How Novo-Catalent Deal Affects Halozyme (HALO)?
Yahoo Finance AU
Laughing Water Capital, an investment management company, released its first-quarter 2024 investor letter.
10 hours ago
Halozyme Therapeutics Shows Rising Relative Price Performance; Still Shy Of Key Benchmark
Investor's Business Daily
In a welcome move, Halozyme Therapeutics (HALO) saw its Relative Strength Rating improve from 69 to 72 on Wednesday.
2 days ago
Halozyme Therapeutics (HALO) Earnings Expected to Grow: Should You Buy?
Zacks Investment Research
Halozyme Therapeutics (HALO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming...
3 days ago
Is Halozyme Therapeutics (NASDAQ:HALO) Using Too Much Debt?
Simply Wall St
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the...
6 days ago
S&P 500 Futures Up in Premarket Trading; Halozyme Therapeutics, Revvity Lead
Barron's
With U.S. stock markets set to open in two hours, Halozyme Therapeutics Inc. (HALO) was up 7.7% in pre-market trading, and Revvity Inc.
3 weeks ago
Halozyme to Report First Quarter 2024 Financial and Operating Results
KRON4
SAN DIEGO, April 23, 2024 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced it will release its first...
1 week ago
Mahesh Krishnan Elected to Halozyme's Board of Directors
ABC27
SAN DIEGO, April 25, 2024 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced the election of Mahesh...
1 week ago
Halozyme to Report First Quarter 2024 Financial and Operating Results
Yahoo Finance
Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced it will release its first quarter 2024 financial and operating...
1 week ago
Halozyme Therapeutics (HALO) Earnings Expected to Grow: Should You Buy?
Yahoo Finance AU
Halozyme Therapeutics (HALO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming...
3 days ago
Why Halozyme Therapeutics (HALO) is a Top Growth Stock for the Long-Term
Yahoo Finance
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors alike.
1 week ago